SEI Investments
COLL icon

SEI Investments’s Collegium Pharmaceutical COLL Stock Holding History

SEI Investments’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.23M Sell
116,828
-13,792
-11% -$471K ﹤0.01% 1580
2026
Q1 		$4.32M Buy
130,620
+85,830
+192% +$3.63M ﹤0.01% 1616
2025
Q4 		$2.07M Buy
44,790
+32,520
+265% +$1.36M ﹤0.01% 1837
2025
Q3 		$429K Buy
12,270
+834
+7% +$29K ﹤0.01% 2308
2025
Q2 		$338K Buy
11,436
+600
+6% +$17.1K ﹤0.01% 2360
2025
Q1 		$323K Buy
10,836
+559
+5% +$17.1K ﹤0.01% 2310
2024
Q4 		$294K Sell
10,277
-4,395
-30% -$145K ﹤0.01% 2363
2024
Q3 		$567K Buy
14,672
+5,174
+54% +$185K ﹤0.01% 2139
2024
Q2 		$306K Sell
9,498
-10,831
-53% -$376K ﹤0.01% 2327
2024
Q1 		$789K Sell
20,329
-109,212
-84% -$3.82M ﹤0.01% 1971
2023
Q4 		$3.99M Sell
129,541
-4,567
-3% -$114K 0.01% 1276
2023
Q3 		$3M Sell
134,108
-13,108
-9% -$299K 0.01% 1402
2023
Q2 		$3.16M Sell
147,216
-10,855
-7% -$246K 0.01% 1428
2023
Q1 		$3.79M Buy
158,071
+20,795
+15% +$551K 0.01% 1321
2022
Q4 		$3.18M Sell
137,276
-837
-0.6% -$16.9K 0.01% 1252
2022
Q3 		$2.21M Sell
138,113
-5,485
-4% -$96.7K ﹤0.01% 1493
2022
Q2 		$2.54M Sell
143,598
-11,207
-7% -$189K 0.01% 1432
2022
Q1 		$3.15M Buy
154,805
+507
+0.3% +$9.58K 0.01% 1341
2021
Q4 		$2.88M Buy
+154,298
New +$3.01M 0.01% 1416
2021
Q3 		– Sell
-8,770
Closed -$207K – 2570
2021
Q2 		$207K Hold
8,770
– – ﹤0.01% 2434
2021
Q1 		$208K Sell
8,770
-1,590
-15% -$37.8K ﹤0.01% 2375
2020
Q4 		$208K Sell
10,360
-46,538
-82% -$909K ﹤0.01% 2346
2020
Q3 		$1.18M Buy
56,898
+8,672
+18% +$157K ﹤0.01% 1533
2020
Q2 		$842K Buy
48,226
+8,958
+23% +$175K ﹤0.01% 1623
2020
Q1 		$639K Buy
+39,268
New +$810K ﹤0.01% 1654
2019
Q2 		– Sell
-4,281
Closed -$62K – 2458
2019
Q1 		$62K Sell
4,281
-14,333
-77% -$230K ﹤0.01% 2584
2018
Q4 		$316K Buy
18,614
+18,566
+38,679% +$318K ﹤0.01% 1880
2018
Q3 		$0 Buy
+48
New +$851 ﹤0.01% 2640

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

SEI Investments's COLL Position: Q2 2026 in Review

SEI Investments reduced its Collegium Pharmaceutical (COLL) stake by 11% in Q2 2026, selling an estimated $471K and leaving 116,828 shares worth $4.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

SEI Investments first reported a position in COLL in Q3 2018 and has held it in 28 quarters since. The position peaked at $4.32M in Q1 2026. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • SEI Investments held 116,828 shares of Collegium Pharmaceutical worth $4.23M as of Q2 2026.
  • SEI Investments sold 13,792 Collegium Pharmaceutical shares in Q2 2026, an estimated $471K.
  • Collegium Pharmaceutical made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1580 holding.
  • SEI Investments first reported a position in Collegium Pharmaceutical in Q3 2018 and has held it in 28 quarters since.
  • SEI Investments's Collegium Pharmaceutical position peaked at $4.32M in Q1 2026.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.